Nanotechnology Now

Our NanoNews Digest Sponsors



Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > CLINATEC Chairman Alim-Louis Benabid Honored By U.S. Research Institute for Parkinsonís Disease Work

Abstract:
CEA-Leti announced today that Prof. Alim-Louis Benabid, chairman of CLINATEC, has been honored by a second major U.S. Parkinson's disease (PD) organization for his work in treating PD.

CLINATEC Chairman Alim-Louis Benabid Honored By U.S. Research Institute for Parkinsonís Disease Work

Grenoble, France | Posted on October 9th, 2013

Benabid received the Jay Van Andel Award for Outstanding Achievement in Parkinson's Disease Research at Van Andel Institute's Grand Challenges in Parkinson's Disease Symposium in September. The award recognizes his invention of deep brain stimulation (DBS), a highly specialized method used to treat specific kinds of neurological diseases, including Parkinson's disease.

"Dr. Benabid has made an incredible contribution to the treatment of Parkinson's disease by developing deep brain stimulation," said Patrik Brundin, director of the Van Andel Institute's Center for Neurodegenerative Science. "Today over 140,000 advanced Parkinson's patients have undergone DBS treatment, which essentially changes the Ďelectric connections' in the brain, and they are able to move remarkably much better thanks to Dr. Benabid's invention."

Benabid, who has received many honors during his career, was awarded the 2013 Robert H. Pritzker Prize for Leadership in Parkinson's Research from the Michael J. Fox Foundation earlier this year.

"The Van Andel Institute's research program has a powerful impact on biomedical research in cancer and Parkinson's disease, with an emphasis on translating scientific research results into clinical applications," Benabid said. "I am honored to receive this award, and I'm proud to highlight the CLINATEC team's ongoing work on infrared brain stimulation to improve treatment of PD, and perhaps severe depression, Alzheimer's disease, Tourette's syndrome and other neurological conditions."

Benabid helped found CLINATEC, the multidisciplinary biomedical research center created by Leti, Grenoble University Hospital, INSERM and Joseph Fourier University in 2009. The center allows medical practitioners, researchers, biologists, and technologists to collaborate on the frontier of health care and micro- and nanoelectronics. Using a unique biomedical and surgery platform, CLINATEC's main objective is to accelerate and make safer the translation of technological innovation for treating patients.

Benabid has centered his scientific activity on the approach of neurosurgical pathologies, particularly brain tumors and movement disorders. From 1989 to 2007, he was head of the Neurosurgery Department at the University Hospital of Grenoble. He currently is a professor emeritus of biophysics at Joseph Fourier University.

####

About CEA-Leti
By creating innovation and transferring it to industry, Leti is the bridge between basic research and production of micro- and nanotechnologies that improve the lives of people around the world. Backed by its portfolio of 2,200 patents, Leti partners with large industrials, SMEs and startups to tailor advanced solutions that strengthen their competitive positions. It has launched more than 50 startups. Its 8,000m≤ of new-generation cleanroom space feature 200mm and 300mm wafer processing of micro and nano solutions for applications ranging from space to smart devices. Letiís staff of more than 1,700 includes 200 assignees from partner companies. Leti is based in Grenoble, France, and has offices in Silicon Valley, Calif., and Tokyo.

About Van Andel Institute

Established by Jay and Betty Van Andel in 1996, Van Andel Institute (VAI) is an independent research and educational organization based in Grand Rapids, Mich., dedicated to preserving, enhancing and expanding the frontiers of medical science, and to achieving excellence in education by probing fundamental issues of education and the learning process. Van Andel Research Institute (VARI), VAIís research arm, is dedicated to studying the genetic, cellular and molecular origins of cancer, Parkinsonís and other diseases and working to translate those findings into effective therapies. This is accomplished through the work of more than 200 researchers in on-site laboratories and in collaborative partnerships that span the globe. Find out more about Van Andel Institute or donate by visiting www.vai.org.

For more information, please click here

Contacts:
CEA-Leti
+33 4 38 78 02 26


Agency
+33 6 64 52 81 10

Copyright © CEA-Leti

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

New non-invasive method can detect Alzheimer's disease early: MRI probe technology shows brain toxins in living animals for first time December 22nd, 2014

Piezoelectricity in a 2-D semiconductor: Berkeley Lab researchers discovery of piezoelectricty in molybdenum disulfide holds promise for future MEMS December 22nd, 2014

Quantum physics just got less complicated December 22nd, 2014

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Nanomedicine

New non-invasive method can detect Alzheimer's disease early: MRI probe technology shows brain toxins in living animals for first time December 22nd, 2014

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Creation of 'Rocker' protein opens way for new smart molecules in medicine, other fields December 18th, 2014

Iranian Researchers Produce Electrical Pieces Usable in Human Body December 18th, 2014

Announcements

New non-invasive method can detect Alzheimer's disease early: MRI probe technology shows brain toxins in living animals for first time December 22nd, 2014

Piezoelectricity in a 2-D semiconductor: Berkeley Lab researchers discovery of piezoelectricty in molybdenum disulfide holds promise for future MEMS December 22nd, 2014

Quantum physics just got less complicated December 22nd, 2014

Enzyme Biosensor Used for Rapid Measurement of Drug December 22nd, 2014

Grants/Awards/Scholarships/Gifts/Contests/Honors/Records

SUNY Poly NanoCollege Faculty Member Selected as American Physical Society Fellow: SUNY Poly Associate Professor of Nanoscience Dr. Vincent LaBella Recognized for Significant Technological Innovations that Enable Interactive Learning December 17th, 2014

ďLine dancing bacteria win the 2014 Dolomite and Lab on a Chip Video CompetitionĒ December 16th, 2014

Lifeboat Foundation gives 2014 Guardian Award to Elon Musk December 16th, 2014

UCLA engineers first to detect and measure individual DNA molecules using smartphone microscope December 15th, 2014

NanoNews-Digest
The latest news from around the world, FREE




  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More










ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE